HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story 6-month HIV PrEP makes coverage gains ...

On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.

Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products ...

Health experts warn new HIV preventive jab does not protect against other STIs, pregnancyHealth experts are welcoming the registration of a twice-yearly injection to prevent HIV, while warning that ...

The Rwanda Biomedical Center (RBC) said last week that the government plans to introduce lenacapavir, a long-acting ...

We're at a crossroads where an end to the epidemic is truly within reach. So what happens next?

Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...

Accusing the state of “reckless maladministration” of the lethal-injection process, an attorney for condemned killer Ronald ...

GoodRx has named 20 medications and vaccines as the most influential FDA approvals of 2025, spotlighting first-in-class drugs, new indications, and therapies with the potential to significantly affect ...

Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the ...